Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome:: an explanation to differences in clinical outcome?

被引:36
作者
Frost, BM
Gustafsson, G
Larsson, R
Nygren, P
Lönnerholm, G
机构
[1] Univ Hosp, Dept Pediat, Uppsala, Sweden
[2] Univ Hosp, Dept Clin Pharmacol, Uppsala, Sweden
[3] Univ Hosp, Dept Oncol, Uppsala, Sweden
[4] Karolinska Hosp, Childhood Canc Res Unit, S-10401 Stockholm, Sweden
关键词
D O I
10.1038/sj.leu.2401753
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:943 / 944
页数:2
相关论文
共 9 条
[1]   Down's syndrome in childhood acute lymphoblastic leukemia:: clinical characteristics and treatment outcome in four consecutive BFM trials [J].
Dördelmann, M ;
Schrappe, M ;
Reiter, A ;
Zimmermann, M ;
Graf, N ;
Schott, G ;
Lampert, F ;
Harbott, J ;
Niemeyer, C ;
Ritter, J ;
Dörffel, W ;
Nessler, G ;
Kühl, J ;
Riehm, H .
LEUKEMIA, 1998, 12 (05) :645-651
[2]  
GLOMSTEIN A, 1999, MED PEDIATR ONCOL, V33, P245
[3]  
Gustafsson G, 1998, ACTA PAEDIATR, V87, P1151
[4]   In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia [J].
Kaspers, GJL ;
Veerman, AJP ;
Pieters, R ;
VanZantwijk, CH ;
Smets, LA ;
VanWering, ER ;
DenBerg, AV .
BLOOD, 1997, 90 (07) :2723-2729
[5]  
KASPERS GJL, 1998, FAVORABLE INVITRO DR
[6]   A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: Best outcome in girls, infants, and children with Down's syndrome [J].
Lie, SO ;
Jonmundsson, G ;
Mellander, L ;
Siimes, MA ;
Yssing, M ;
Gustafsson, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (01) :82-88
[7]  
NYGREN P, 1992, LEUKEMIA, V6, P1121
[8]  
RAVINDRANATH Y, 1992, BLOOD, V80, P2210
[9]   Myeloblasts from Down syndrome children with acute myeloid leukemia have increased in vitro sensitivity to cytosine arabinoside and daunorubicin [J].
Taub, JW ;
Stout, ML ;
Buck, SA ;
Huang, X ;
Vega, RA ;
Becton, DL ;
Ravindranath, Y .
LEUKEMIA, 1997, 11 (09) :1594-1595